Patrick J. McEnany, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 269,190 shares at $21.19 ($5.7M) on 2024-11-19, disclosed to the SEC on 2024-11-21.
Open-market sale of $5.7M CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.19 | 98,345 | $2.1M | 36.5% |
| 2 | $21.19 | 98,345 | $2.1M | 36.5% |
| 3 | $21.29 | 72,500 | $1.5M | 27.0% |
| Total | $21.22 avg | 269,190 | $5.7M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |
| CPRX | SELL | 2022-11-22 | $7.8M | — | Filing → |